(1) A pharmacy licensed under this chapter may, subject to rules established by the division, repackage or compound a prescription drug for sale to a practitioner if: (a) the prescription drug: (i) does not include a compounded drug; or (ii) (A) includes a compounded drug; and (B) is not a controlled substance; (b) the pharmacy labels the prescription drug "for office use only"; (c) the practitioner administers the drug to a patient in the practitioner's office or facility; and (d) except in accordance with Title 58, Chapter 17b, Part 8, Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy, the practitioner does not dispense the drug to the patient.

(a) the prescription drug: (i) does not include a compounded drug; or (ii) (A) includes a compounded drug; and (B) is not a controlled substance;

(i) does not include a compounded drug; or

(ii) (A) includes a compounded drug; and (B) is not a controlled substance;

(A) includes a compounded drug; and

(B) is not a controlled substance;

(b) the pharmacy labels the prescription drug "for office use only";

(c) the practitioner administers the drug to a patient in the practitioner's office or facility; and

(d) except in accordance with Title 58, Chapter 17b, Part 8, Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy, the practitioner does not dispense the drug to the patient.

(2) The division shall establish, in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, prescription drug labeling and control standards for a prescription drug that a pharmacy provides to a practitioner under this section.